Marek Hus
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 70
- Multiple Myeloma Research and Treatments 54
- Acute Myeloid Leukemia Research 7
- Hematopoietic Stem Cell Transplantation 6
- Genetics 30
- Chronic Lymphocytic Leukemia Research 23
- Myeloproliferative Neoplasms: Diagnosis and Treatment 7
- Co-authors
- Norbert Grząśko (14 shared papers)Anna Dmoszyńska (21 shared papers)Marta Morawska (8 shared papers)Sylwia Chocholska (23 shared papers)Maria Soroka‐Wojtaszko (8 shared papers)Grzegorz Helbig (13 shared papers)Agnieszka Szymczyk (17 shared papers)Monika Podhorecka (10 shared papers)
- Journals
- Blood (6 papers)Hematological Oncology (4 papers)Cancers (4 papers)British Journal of Haematology (4 papers)Oncotarget (4 papers)
- Partner nations
- PolandUnited StatesCzechia
In The Last Decade
Marek Hus
116 papers receiving 1.8k citations
Marek Hus's Hit Papers
Peers
Comparison fields: 5 of 74
- Hematology 850
- Genetics 368
- Rheumatology 118
- Oncology 152
- Immunology 82
Countries citing papers authored by Marek Hus
This map shows the geographic impact of Marek Hus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Hus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Hus more than expected).
Fields of papers citing papers by Marek Hus
This network shows the impact of papers produced by Marek Hus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Hus. The network helps show where Marek Hus may publish in the future.
Co-authors
The 25 scholars most cited alongside Marek Hus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 131 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial Hit paper breakdown → | 2019 | 319 |
| 2 | Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study Hit paper breakdown → | 2023 | 146 |
| 3 | Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma Hit paper breakdown → | 2024 | 108 |
| 4 | Thalidomide treatment of resistant or relapsed multiple myeloma patients. | 2001 | 78 |
| 5 | 2014 | 63 | |
| 6 | 2022 | 53 | |
| 7 | 2011 | 52 | |
| 8 | 2016 | 46 | |
| 9 | 2012 | 42 | |
| 10 | 2019 | 42 | |
| 11 | 2023 | 39 | |
| 12 | 2017 | 36 | |
| 13 | 2024 | 36 | |
| 14 | 2002 | 34 | |
| 15 | 2017 | 31 | |
| 16 | 2011 | 27 | |
| 17 | 2014 | 26 | |
| 18 | 2019 | 25 | |
| 19 | 2009 | 23 | |
| 20 | 2019 | 23 |
About Marek Hus
Marek Hus is a scholar working on Hematology, Genetics, Oncology, Rheumatology and Immunology, having authored 131 papers that have together received 1.8k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (54 papers), Chronic Lymphocytic Leukemia Research (23 papers), Eosinophilic Disorders and Syndromes (8 papers), Acute Myeloid Leukemia Research (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers), Hematopoietic Stem Cell Transplantation (6 papers), Neutropenia and Cancer Infections (4 papers) and Mast cells and histamine (3 papers). The work is most often cited by research in Hematology (850 citations), Genetics (368 citations), Rheumatology (118 citations), Oncology (152 citations) and Immunology (82 citations). Marek Hus has collaborated with scholars based in Poland, United States and Czechia. Frequent co-authors include Norbert Grząśko, Anna Dmoszyńska, Marta Morawska, Sylwia Chocholska, Maria Soroka‐Wojtaszko, Grzegorz Helbig, Agnieszka Szymczyk, Monika Podhorecka, Sławomira Kyrcz‐Krzemień and Wojciech Maciej Legiec. Their work appears in journals such as Blood, Hematological Oncology, Cancers, British Journal of Haematology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.